Skip to content
Trial Eligibility
Menu

Effect of Menthol on ENDS Users' Addiction and Exposure

NCT05338801

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The use of electronic nicotine delivery systems (ENDS; e-cigarettes) has reached epidemic levels among young people in the United States (US). ENDS heat and vaporize a nicotine-containing liquid to produce an inhalable aerosol mist. While generally considered less harmful than combustible cigarettes, ENDS use exposes users to dependence-producing nicotine and respiratory and cardiovascular toxicants such as aldehydes.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Electronic Cigarette Use

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
21 to 35 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Florida International University
Last updated on ClinicalTrials.gov
April 1, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 1

  • Florida International University · Miami, FL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.